Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000059

Options or other derivatives

  • EVP, Regulatory Affairs acquired 230,953 shares (grant or award)
  • EVP, Regulatory Affairs returned 346,425 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −48,500 0 D: show line 1 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −13,750 0 D: show line 2 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −34,175 0 D: show line 3 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −28,250 0 D: show line 4 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −31,750 0 D: show line 5 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Returned to the company · Stock Option (Right to Buy) −190,000 0 D: show line 6 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Grant or award · Stock Option (Right to Buy) +32,334 32,334 D: show line 7 in the form
Peterson Caryn EVP, Regulatory Affairs 2023-05-05 Grant or award · Stock Option (Right to Buy) +9,167 9,167 D: show line 8 in the form
Loading xslF345X04/wf-form4_168366387285335.xml…